Skip to main content
Clinical Trials/CTRI/2024/05/067272
CTRI/2024/05/067272
Not yet recruiting
Phase 3

Randomized comparative clinical trial of efficacy of Agnikarma with and without Laghusutashekhra rasa in the management of Ardhavabhedaka w.s.r. to Migraine without aura - Nil

Shekh Afreen Naaz0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G09- Sequelae of inflammatory diseasesof central nervous system
Sponsor
Shekh Afreen Naaz
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Shekh Afreen Naaz

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients between age group 18 to 60 years.
  • 2\. Patient’s fulfilling the diagnostic symptoms of Ardhavbhedaka like \- recurrent attacks of headache(shirovedana), mostlyunilateral in site, variable in intensity, frequency and duration with or without nausea (hrullasa), vomiting (chardi), vertigo (bhrama) will be selected
  • randomly irrespective of age, sex, religion and occupation.
  • 3\. Patients fit for Agnikarma.

Exclusion Criteria

  • 1\. Any other known systemic disorders which will affect or
  • interfere course of treatment e.g., Hypertension, DM
  • 2\. Patient’s not fit for Agnikarma19
  • 3\. Secondary headache caused due to meningitis, encephalitis,
  • cervical spondylosis.
  • 4\. Referred pain due to diseases of eye, ear, nose, teeth etc.
  • 5\. Patients with complicated migraine that is complications
  • like loss of hearing, loss of vision.

Outcomes

Primary Outcomes

Not specified

Similar Trials